Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact
Search
Close
Enter Search Terms
Search
James Xu
ID:
1b83aac0-2619-30fb-68c4
/
Unclaimed
/
Organization:
Goodwin Procter
Published Works
3 articles
Formycon/Fresenius Kabi and Samsung Bioepis Settlements with J&J and Janssen Biotech regarding Ustekinumab
Big Molecule Watch ·
August 16, 2023
cite
Similis Bio and Blau Farmaceutica Enter into Development and License Agreement for Biosimilars
Big Molecule Watch ·
November 7, 2022
cite
Clinical Trial Updates: Insulin Glargine and Trastuzumab Biosimilars
Big Molecule Watch ·
April 7, 2022
cite